Zucara Therapeutics announced highly positive results from its proof-of-concept Phase 1b trial of ZT-01 in people with Type 1 diabetes (“T1D”). Please see the press release here. Why this news is important: This trial confirms ZT-01’s…
Our startup company, Phenotips (formerly Gene42), announced in September, 2021, that it raised C$2.5M in its first round of financing. TIAP was an early investor and most recently, in this…
LSO - Life Sciences Ontario - prepared an in-depth and informative report on the importance of the life science sector in Ontario. TIAP was one of the endorsing organizations. The…
7D Surgical was acquired by SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders. The agreement is a cash and…
In February 2021, Miroculus closed a Series B financing extension bringing the total capital raised in the round to $45 million. bwnews.pr/3s9abDsbwnews.pr/3s9abDs
TIAP portfolio company Notch Therapeutics has announced one of the largest Series A financing rounds in the history of Canadian biotech. We are proud to say that we were there…
On February 24, 2021 TIAP hosted a LAB150 webinar entitled Adventures in Drug Hunting: Identify and Advance Your Drug-Like Molecule. Here is the full description of the webinar content: In the…
December 8, 2020 TIAP announces co-funding of transformative projects with Amgen to support new venture development Toronto Innovation Acceleration Partners (TIAP) is excited to announce co-investments made with a key…
Staying on Target: How to Determine if Your Research Program is Ready for Drug Discovery LAB150 Presents: A 3-part Webinar Series on Drug Discovery and Development November 17, 2020 -…
November 2, 2020: Zucara Therapeutics Inc., a diabetes life sciences startup funded by TIAP and adMare BioInnovations, announced today that it has received funding from NRC IRAP and MITAS for…
Schwartz Reisman Innovation Campus, West Tower
108 College Street, Suite 530
Toronto, ON M5G 0C6
info@tiap.ca